The Real-World Evidence (RWE) function is part of the Clinical Data Science (CDS) department within the Development organization and aims to unlock the power of real-world evidence to help transform health innovations into life-changing medicines for patients. CDS-RWE conducts observational research and generates analysis results to inform decisions throughout the product lifecycle across research, development, post-approval, and commercialization. Observational research is conducted on data collected from individuals assessed for biomedical, health and other outcomes, and includes observational studies and observational analyses. Source data to generate the analysis results may be based on primary data collection, secondary data use, or both. These analysis results, generated using a rigorous process, provide insights and evidence for internal (e.g., program, safety) and external (e.g., regulators, healthcare providers) stakeholders. Position Summary: The Associate Director, Analysis Oversight Lead RWE Safety: Inflammation position is responsible for the oversight of timeliness and quality of safety programming and analysis deliverable supporting the CDS-RWE Inflammation therapeutic area (TA). This role reports to the CDS-RWE Safety Epidemiologist Lead and partners with CDS-RWE scientific leads and Patient Safety stakeholders to translate safety analysis requirements into high-quality, compliant programming and analysis deliverables. Serving as the primary point of contact for analysis vendors and service vendors, this role is responsible for planning, execution, and quality acceptance of safety analysis deliverables. The position requires demonstrated experience in managing complex analytical workflows to generate analysis results in a GxP compliant programming environment to meet time-critical deadlines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees